Care Access - Greensboro

Greensboro, North Carolina 27401

0 studies enrolling now · 1 studies all time

What they study most

Alzheimer Disease

Studies at this site

• A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3) — Running, not enrolling